Open Targets
banner
opentargets.org
Open Targets
@opentargets.org
Public-private partnership using human genetics and genomics data for systematic drug target identification and prioritisation. http://blog.opentargets.org
And that's the Open Targets Hackathon done! 🧬🖥️

Thank you to everyone who joined in person and online, and who contributed to make this event a success

Particular thanks to our sponsors: Gates Foundation, Google Cloud, and @thehyvenl.bsky.social 🎉
October 23, 2025 at 12:26 PM
Open Targets Hackathon Day 1!

Following our official kick off yesterday, there was some incredible energy and focus in the room

Thanks to our sponsors Gates Foundation, Google Cloud, and @thehyvenl.bsky.social for making this possible!
October 22, 2025 at 9:39 AM
The Open Targets Hackathon is today! 🎉

We're super excited to kick off this event celebrating 10 years of the Open Targets Platform

Thank you to Google Cloud for sponsoring our compute and Hariprasad Radhakrishnan for mentoring our teams and sharing this video — made with Google Veo 3! 🖥️🧬
October 21, 2025 at 11:24 AM
At #ASHG25 and want to find out more about the largest and most comprehensive systematic analysis of common variation in humans?

Go find Daniel at poster board 1014T!
October 16, 2025 at 2:50 PM
We're at #ASHG2025!

Come say hello and find out more about Open Targets projects 👋
October 14, 2025 at 9:44 AM
October 3, 2025 at 9:54 AM
Out now in Nature Comms: the largest trans-eQTL meta-analysis in a single cell type!

An Open Targets team led by Krista Freimann and @kauralasoo.bsky.social analysed 3,734 lymphoblastoid cell line samples across nine cohorts, identifying four robust loci

www.nature.com/articles/s41...
Trans-eQTL mapping prioritises USP18 as a negative regulator of interferon response at a lupus risk locus - Nature Communications | Open Targets
Out now in Nature Comms: the largest trans-eQTL meta-analysis in a single cell type! An Open Targets team led by Krista Freimann and Kaur Alasoo analysed 3,734 lymphoblastoid cell line samples across...
www.linkedin.com
October 2, 2025 at 11:59 AM
CLOSING:

➡️ Senior Bioinformatician with Roser Vento Tormo
sanger.wd103.myworkdayjobs.com/en-US/Wellco...

➡️ Technical Specialist (neuro) with Omer Ali Bayraktar
sanger.wd103.myworkdayjobs.com/en-US/Wellco...

Both @sangerinstitute.bsky.social roles close on 2 October
Technical Specialist: Neurodegenerative Disease Spatial Transcriptomics and Data Generation
Do you want to help us improve human health and understand life on Earth? Make your mark by shaping the future to enable or deliver life-changing science to solve some of humanity’s greatest challenge...
sanger.wd103.myworkdayjobs.com
September 25, 2025 at 9:27 AM
Reposted by Open Targets
Excited for a major milestone in our efforts to map enhancers and interpret variants in the human genome:

The E2G Portal! e2g.stanford.edu

This collates our predictions of enhancer-gene regulatory interactions across >1,600 cell types and tissues.

Uses cases 👇

1/
September 18, 2025 at 4:14 PM
The Open Targets Platform autumn release is out! 🍂

We have ingested the full dataset of over 13 million enhancer-gene regulatory interactions in the human genome across 1,458 DNase-seq experiments covering 369 cell types and tissues from the ENCODE-rE2G model

blog.opentargets.org/open-targets...
Open Targets Platform 25.09 has been released!
The September 25 release includes enhancer-gene data predicted by ENCODE-rE2G, molQTL credible sets for targets, new options for the variant structural viewer, and a number of data updates from GWAS C...
blog.opentargets.org
September 18, 2025 at 10:39 AM
Reposted by Open Targets
🚩1 MILLION curated associations!!! 🚩
Launched in 2008, took us 15 years to reach 500K, and thanks to your research and collaboration, we doubled the number in less than 3 years!
See some data insights tinyurl.com/mw53njbb
#OpenAccess
September 16, 2025 at 1:12 PM
Last call to submit a project for the Open Targets Hackathon!

Submit a project by 12 September: docs.google.com/forms/d/e/1F...

We will prioritise projects where the project leads have signed up to attend the hackathon. Registrations are currently full but you can sign up to the waiting list
September 4, 2025 at 10:54 AM
Out now on bioRxiv! 🧬🖥️

A team from the Cowley, Bassett, and @gosiatrynka.bsky.social labs integrate pooled iPSC phenotyping, transcriptomics, and CRISPR perturbations to identify genetic drivers of molecular and cellular phenotypes in microglia

www.biorxiv.org/content/10.1...
#neuroskyence
Integrated QTL mapping and CRISPR screening in pooled iPSC-derived microglia reveals genetic drivers of neurodegenerative risk
Mounting evidence implicates microglia in neurodegeneration, but linking disease-associated genetic variants to target genes and cellular phenotypes is hindered by the inaccessibility of these cells. ...
www.biorxiv.org
August 26, 2025 at 10:16 AM
Out now! 🧬

Lewis Evans and the team at @sangerinstitute.bsky.social and UCL define the pathways for tau entry into human neurons, a key mechanism for the progression of tauopathies associated with Parkinson’s and Alzheimer’s disease

www.embopress.org/doi/full/10....

#neuroscience #neuroskyence
Tau uptake by human neurons depends on receptor LRP1 and kinase LRRK2 | The EMBO Journal
imageimageNeuronal uptake of extracellular tau protein is thought to propagate intracellular protein aggregation between neurons, contributing to the pathogenesis of Alzheimer’s and other neurodegener...
www.embopress.org
August 19, 2025 at 10:31 AM
CLOSING: Front end developer for the Open Targets Platform

Join @carcruz.dev's team and help us turn complex data into powerful discovery tools, working closely with our industry and academic partners

Apply by 19 August

embl.wd103.myworkdayjobs.com/EMBL/job/Hin...

#ReactJobs #DevJobs
Front-End Web Developer
We are looking for an exceptional Web Developer to join Open Targets at EMBL-EBI. Join Open Targets at EMBL-EBI as a Web Developer and help transform vast biomedical data into insights that drive safe...
embl.wd103.myworkdayjobs.com
August 12, 2025 at 10:09 AM
NEW: Front-End Web Dev @ebi.embl.org

Join the Open Targets Platform team!

Design and build this cloud-first, open-source application, used to explore and prioritise potential drug targets

embl.wd103.myworkdayjobs.com/EMBL/job/Hin...
Front-End Web Developer
We are looking for an exceptional Web Developer to join Open Targets at EMBL-EBI. Join Open Targets at EMBL-EBI as a Web Developer and help transform vast biomedical data into insights that drive safe...
embl.wd103.myworkdayjobs.com
August 7, 2025 at 9:59 AM
“It’s been a very collaborative experience.”

@malloryfreeberg.bsky.social talks to us about developing the Perturbation Catalogue

The beta version is available to explore now, and the team are keen to hear your feedback!
www.ebi.ac.uk/perturbation...

blog.opentargets.org/creating-a-p...
Why Mallory Freeberg is creating a perturbation catalogue
The Perturbation Catalogue is an Open Targets project which aims to bring genetic perturbation data into one curated, harmonised, and discoverable platform. Mallory Freeberg, one of the project leads,...
blog.opentargets.org
August 5, 2025 at 11:54 AM
Google Cloud is sponsoring the compute for the Open Targets hackathon!

There is now a waiting list to attend the event in person, but project submissions and online registrations are still open.

The two-day hackathon will explore data, analyses, and tools for target discovery
July 31, 2025 at 9:09 AM
Meet Carlos Cruz! Carlos joined the Open Targets Platform team in 2021 🖥️🧬

@carcruz.dev, what is your role in Open Targets?
July 29, 2025 at 9:46 AM
We're proud to play our part in diversifying genetic and genomic datasets by supporting this important work in Latin America co-led by Open Targets Science Director @gosiatrynka.bsky.social

Greater genetic diversity improves discovery and brings us closer to better, more inclusive medicines
July 28, 2025 at 8:39 AM
Reposted by Open Targets
🧬 New @emblebi.bsky.social service beta launched:
Perturbation Catalogue

🔎 Browse genetic perturbation datasets
🧠 Train models
🧬 Interpret variant function
🧭 Explore gene dependencies

Search, test APIs, suggest datasets, send feedback!
🔗 www.ebi.ac.uk/perturbation...

Funded by @opentargets.org
July 23, 2025 at 10:06 AM
We have now deprecated Open Targets Genetics — it has been superseded by the Open Targets Platform

The team said goodbye to Open Targets Genetics, through the medium of memes

Enjoy!
July 10, 2025 at 9:17 AM
Reposted by Open Targets
Open licenses power discovery!

Melissa Harrison shares a @opentargets.org use case:

Open Targets identifies and prioritises drug targets using AI to extract gene, drug, and disease mentions and relationships to building drug development evidence

#ChooseOpenWebinar for updates 💡
#MedLib #PhDsky
July 9, 2025 at 4:16 PM
Open Targets Genetics has now been deprecated

It has been superseded by the Open Targets Platform
July 9, 2025 at 1:25 PM
Reposted by Open Targets
Delighted to share the first preprint of my postdoc in the @carlanderson.bsky.social lab www.medrxiv.org/content/10.1...! 🚨 A super exciting study I co-led with the very talented @tobioinformatics.bsky.social . Stay tuned to see what we learned about genetic susceptibility to complex disease. 🧬🧵 1/
Cell-type-resolved genetic regulatory variation shapes inflammatory bowel disease risk
Most genetic variants associated with complex diseases lie in non-coding regions, complicating efforts to identify effector genes and relevant cell types. Here, we map cis-eQTLs across 2.2 million sin...
www.medrxiv.org
July 8, 2025 at 8:51 AM